Major Announcements for Axplora
March 2, 2026
CDMO announces multi-million-euro investment to expand lyophilization and appoints Head of Site
1 min read
False
March 2, 2026
CDMO announces multi-million-euro investment to expand lyophilization and appoints Head of Site
1 min read
February 27, 2026
Ahead of Rare Disease Day, leaders from iHope and PacBio explore how technology, collaboration, and policy reform can bring accurate genomic diagnosis
6 min read
February 25, 2026
Collaboration anchored in Syngene’s SynVent platform and Connector model to accelerate promising academic research
1 min read
February 24, 2026
KinetiSol’s solvent-free mixing process turns “brick dust” drugs into stable amorphous dispersions
5 min read
February 23, 2026
An Interview with Adam Davenport, CSO, Concept Life Sciences
4 min read
February 20, 2026
Integrated, risk-based chemistry, manufacturing and controls strategies support early-phase development, writes Richard Chubb
6 min read
February 18, 2026
Greg Thomas, Kiel Laboratories’ Vice President of R&D, discusses oral suspensions, excipients, and patient-centered formulation
4 min read
February 17, 2026
Phase 3 results show fenebrutinib matched OCREVUS on disability progression in PPMS
2 min read
February 16, 2026
Part of a broader multibillion-dollar effort to expand R&D and manufacturing in the US
1 min read
By Martyn Williams
February 16, 2026
UK pharma’s digital ambition is starting to work against it, writes Martyn Williams of COPA-DATA UK
3 min read
False
False
False